Search

Search Constraints

You searched for: Author/Creator Blanchet, Odile

Search Results

1. Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population. (November 2018)

2. Next generation sequencing redefines a triple negative essential thrombocythaemia as double‐positive with rare mutations on JAK2 V617 and MPL W515 hotspots. (14th May 2019)

3. Sequential mutational evaluation of CALR ‐mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression. (11th November 2019)

4. Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial. (August 2021)

5. A plasma metabolomic signature of Leber hereditary optic neuropathy showing taurine and nicotinamide deficiencies. Issue 1 (12th January 2021)

6. Imatinib Treatment of Chronic Myeloid Leukemia Reveals a Preexisting CALR-mutated Essential Thrombocythemia. Issue 1 (January 2018)

7. Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate‐risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006‐intermediate‐risk trial. (18th April 2021)

8. Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network. (July 2021)

9. Metabolomic signature of the seminal plasma in men with severe oligoasthenospermia. (31st August 2020)

10. Donor cell‐derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation. (3rd September 2018)